Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Acute Kawasaki Disease With Coronary Artery Abnormalities
NCT07530640Phase 3Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jun 2026
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 3 trial of atorvastatin in Kawasaki disease (KD), coronary artery anomalies (CAA), sponsored by Children's Hospital of Fudan University. Started Jun 2026; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
Kawasaki disease (KD)coronary artery anomalies (CAA)
Beyond the preview
Go deeper on NCT07530640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07530640.